SE352347B - - Google Patents

Info

Publication number
SE352347B
SE352347B SE1265068A SE1265068A SE352347B SE 352347 B SE352347 B SE 352347B SE 1265068 A SE1265068 A SE 1265068A SE 1265068 A SE1265068 A SE 1265068A SE 352347 B SE352347 B SE 352347B
Authority
SE
Sweden
Application number
SE1265068A
Inventor
J Ufel
O Engelfried
R Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE352347B publication Critical patent/SE352347B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE1265068A 1967-10-04 1968-09-19 SE352347B (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESC041382 1967-10-04

Publications (1)

Publication Number Publication Date
SE352347B true SE352347B (xx) 1972-12-27

Family

ID=7436199

Family Applications (1)

Application Number Title Priority Date Filing Date
SE1265068A SE352347B (xx) 1967-10-04 1968-09-19

Country Status (12)

Country Link
AT (1) AT297946B (xx)
BE (1) BE721825A (xx)
BR (1) BR6802861D0 (xx)
CS (1) CS150596B2 (xx)
DK (1) DK122125B (xx)
FI (1) FI45551C (xx)
FR (2) FR1584879A (xx)
GB (1) GB1246639A (xx)
IE (1) IE32405B1 (xx)
NL (1) NL160835C (xx)
SE (1) SE352347B (xx)
YU (1) YU33834B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63267722A (ja) * 1987-04-27 1988-11-04 Daiichi Yakuhin Sangyo Kk 抗肥満症剤
US4835147A (en) * 1987-05-06 1989-05-30 City Of Hope Dehydroepiandrosterone therapy for ameleoration of prostate hypertrophy and sexual dysfunction
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
ATE275957T1 (de) * 1993-01-19 2004-10-15 Endorech Inc Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron
US5407927A (en) * 1993-04-16 1995-04-18 The Regents Of The University Of California Treatment of mild depression and restoration of IGF-I levels in aging by dehydroepiandrosterone
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
CN110585124A (zh) * 2019-09-26 2019-12-20 西安力邦医药科技有限责任公司 一种含有雌三醇或其衍生物的油性注射剂

Also Published As

Publication number Publication date
AT297946B (de) 1972-03-15
NL160835B (nl) 1979-07-16
DE1643046A1 (de) 1971-06-16
NL160835C (nl) 1979-12-17
FR1584879A (xx) 1970-01-02
IE32405B1 (en) 1973-07-25
FI45551B (xx) 1972-04-04
GB1246639A (en) 1971-09-15
BR6802861D0 (pt) 1973-03-15
FI45551C (fi) 1972-07-10
IE32405L (en) 1969-04-04
BE721825A (xx) 1969-04-04
CS150596B2 (xx) 1973-09-04
YU33834B (en) 1978-06-30
FR8191M (xx) 1970-09-07
NL6814196A (xx) 1969-04-09
DE1643046B2 (de) 1975-11-27
DK122125B (da) 1972-01-24
YU224068A (en) 1977-12-31

Similar Documents

Publication Publication Date Title
AU425114B2 (xx)
AT298283B (xx)
FI45551B (xx)
AU416737B2 (xx)
AU2277767A (xx)
AU342066A (xx)
AU2977667A (xx)
AU2528767A (xx)
AU2256867A (xx)
AU610966A (xx)
AU2116667A (xx)
AU1273466A (xx)
AU3189468A (xx)
AU34866A (xx)
BE711497A (xx)
BE711425A (xx)
BE711371A (xx)
BE710530A (xx)
BE710025A (xx)
AU2406369A (xx)
BE692780A (xx)
AU3054676A (xx)
AU23366A (xx)
AU408412B2 (xx)
AU1614766A (xx)